AB SCIEX Expands Software Capability To Include DiscoveryQuantTM 3.0 Software For The High Throughput Pharmaceutical Laboratory

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX, a global leader in life science analytical technologies, today introduced DiscoveryQuant 3.0 Software, a new version of its proven ADME software that enables scientists to significantly reduce LC/MS method development and optimization time for high throughput drug discovery (ADME) laboratories focusing on both small molecules and biotherapeutics. Scientists can now make better decisions about drug candidates faster, as DiscoveryQuant 3.0 software reduces tedious LC/MS method development time with a fast, robust, and reliable process that optimizes methods for hundreds of small and/or large molecules.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC